Publication & Citation Trends
Publications
0 total
Abstract 2869: ADG138, a novel HER2×CD3 POWERbody™ integrating bispecific TCE with precision masking to control cytokine release syndrome and on-target off-tumor toxicity for single agent and combination therapies in HER2-expressing solid tumors
Cited by 1
Semantic Scholar
Abstract 4257: ADG153-G1, a highly differentiated anti-CD47 IgG1 SAFEbody, demonstrates potent in vivo anti-tumor activities with enhanced ADCC/ADCP effects and significantly reduced RBC-related and antigen sink liabilities
Cited by 0
Semantic Scholar
ADG152, a Novel CD20xCD3 T Cell Engager Prodrug with Enhanced Therapeutic Index, Demonstrates Strong Anti-Tumor Activity with Improved Safety OA
Cited by 0
Semantic Scholar
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study OA
Cited by 13
Semantic Scholar
ADG153, an Anti-CD47 Monoclonal Antibody Prodrug, Has Strong In Vivo Anti-Tumor Activity, Minimal RBC-Related and Antigen Sink Liabilities, and Extended Half Life in Comparison with Benchmark Clinical Antibodies of the Same IgG Subclass OA
Cited by 3
Semantic Scholar
Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors OA
Cited by 23
Semantic Scholar
Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome OA
Cited by 53
Semantic Scholar
Multi-omics analysis of AML cells treated with azacitidine reveals highly variable cell surface proteome remodeling OA
Cited by 1
Semantic Scholar
Research Topics
Acute Myeloid Leukemia Research
(12)
Cancer, Hypoxia, and Metabolism
(10)
Epigenetics and DNA Methylation
(8)
Cancer Treatment and Pharmacology
(8)
Lung Cancer Treatments and Mutations
(6)
Affiliations
Albert Einstein College of Medicine
California State University, Fullerton
Veterans Health Administration
AbbVie (United States)
Moffitt Cancer Center